Skip to main content
OpenTrials

Clinical trial condition

Blindness

Explore clinical trials studying Blindness. Study availability and eligibility vary by location and protocol.

99 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Blindness trial results

Active, Not Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

NCT06856577

Conditions
Blindness, Eye Diseases, Neovascular Age-related Macular Degeneration (nAMD), +7 more
Locations
  • Adverum Clinical Site 223 Gilbert, Arizona, United States
  • Adverum Clinical Site 178 Phoenix, Arizona, United States
  • Adverum Clinical Site 126 Phoenix, Arizona, United States
  • Adverum Clinical Site 229 Scottsdale, Arizona, United States
View all 75 locations
View Trial Details
Active, Not Recruiting

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

NCT04645212

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +18 more
Locations
  • Adverum Clinical Site Bakersfield, California, United States
  • Adverum Clinical Site Beverly Hills, California, United States
  • Adverum Clinical Site Lakewood, Colorado, United States
  • Adverum Clinical Site Deerfield Beach, Florida, United States
View Trial Details
Active, Not Recruiting

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

NCT05536973

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +16 more
Locations
  • Adverum Clinical Site 178 Phoenix, Arizona, United States
  • Adverum Clinical Site 126 Phoenix, Arizona, United States
  • Adverum Clinical Site 159 Tucson, Arizona, United States
  • Adverum Clinical Site 100 Beverly Hills, California, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

NCT05607810

Conditions
Blindness, Cardiovascular Diseases, Diabetes Complications, +14 more
Locations
  • Adverum Clinical Site Beverly Hills, California, United States
  • Adverum Clinical Site Reno, Nevada, United States
  • Adverum Clinical Site Philadelphia, Pennsylvania, United States
  • Adverum Clinical Site Austin, Texas, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)

NCT03913143

Conditions
Blindness, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations
  • University of Iowa Iowa City, Iowa, United States
  • Universitair Ziekenhuis Gent (UZ) Ghent, Belgium
  • INRET Clínica/ Santa Casa de Misericórdia de Belo Horizonte Belo Horizonte, Minas Gerais, Brazil
  • Federal University of São Paulo - Hospital São Paulo (UNIFESP-HSP) São Paulo, Brazil
View all 14 locations
View Trial Details

Related conditions